Screening at 11-13+6 weeks' gestation

J 2012

Screening at 11-13+6 weeks' gestation

SONEK, J.D., K.H. NICOLAIDES a Petr JANKŮ

Základní údaje

Originální název

Screening at 11-13+6 weeks' gestation

Název česky

Screening v 11.-13.+6 týdnu těhotenství

Autoři

SONEK, J.D. (840 Spojené státy, garant), K.H. NICOLAIDES (826 Velká Británie a Severní Irsko) a Petr JANKŮ (203 Česká republika, domácí)

Vydání

Česká gynekologie, Česká Republika, Česká Lékařská společnost J.E.Purkyně, 2012, 1210-7832

Další údaje

Jazyk

angličtina

Typ výsledku

Článek v odborném periodiku

Obor

30214 Obstetrics and gynaecology

Stát vydavatele

Česká republika

Utajení

není předmětem státního či obchodního tajemství

Kód RIV

RIV/00216224:14110/12:00064029

Organizační jednotka

Lékařská fakulta

Klíčová slova česky

screening v I. trimestru těhotenství; trisomie 21; aneuploidie; nuchální projasnění; dodatečné markery PAPP-A; free beta-hCG; vady neurální trubice; preeklampsie

Klíčová slova anglicky

first-trimester screening; trisomy 21; aneuploidies; nuchal translucency; additional markers; serum PAPP-A; serum free beta-hCG; open neural tube defects; preeclampsia

Příznaky

Recenzováno

Změněno: 23. 2. 2013 23:48, Ing. Mgr. Věra Pospíšilíková

Anotace

V originále

Ultrasound examination of the conccptus and the uterine blood supply between 11 and 13 weeks' gestation provides important information about the state of the pregnancy at that point in time and about its future progress. Nuchal translucency measurement in conjunction with maternal serum markers (free-p -human chorionic gonailoiropin and pregnancy-associated plasma protein-A), has been shown to be a highly effective method for screening for aneuploidy. This is further improved by the addition of other more recently discovered first trimester ultrasound markers resulting in detection rates that exceed 90% with a false positive rate of 2.5%. Many fetal structural anomalies can be detected at this gestational age. Recently described first trimester evaluation of the posterior brain (intracranial translucency (IT)) provides an effective screening tool for the presence of open neural tube defects. Doppler measurement of the pulsatility index in the uterine arteries in conjunction with maternal history and examination as well as maternal serum biochemistries helps to accurately establish the risk of developing preeclampsia.

Citovat

SONEK, J.D., K.H. NICOLAIDES a Petr JANKŮ. Screening at 11-13+6 weeks' gestation. Česká gynekologie. Česká Republika: Česká Lékařská společnost J.E.Purkyně, 2012, roč. 77, č. 2, s. 92-104. ISSN 1210-7832.

@article{1088561,
   author = {Sonek, J.D. and Nicolaides, K.H. and Janků, Petr},
   article_location = {Česká Republika},
   article_number = {2},
   keywords = {first-trimester screening; trisomy 21; aneuploidies; nuchal translucency; additional markers; serum PAPP-A; serum free beta-hCG; open neural tube defects; preeclampsia},
   language = {eng},
   issn = {1210-7832},
   journal = {Česká gynekologie},
   title = {Screening at 11-13+6 weeks' gestation},
   volume = {77},
   year = {2012}
}

TY  - JOUR
ID  - 1088561
AU  - Sonek, J.D. - Nicolaides, K.H. - Janků, Petr
PY  - 2012
TI  - Screening at 11-13+6 weeks' gestation
JF  - Česká gynekologie
VL  - 77
IS  - 2
SP  - 92-104
EP  - 92-104
PB  - Česká Lékařská společnost J.E.Purkyně
SN  - 12107832
KW  - first-trimester screening
KW  - trisomy 21
KW  - aneuploidies
KW  - nuchal translucency
KW  - additional markers
KW  - serum PAPP-A
KW  - serum free beta-hCG
KW  - open neural tube defects
KW  - preeclampsia
N2  - Ultrasound examination of the conccptus and the uterine blood supply between 11 and 13 weeks' gestation provides important information about the state of the pregnancy at that point in time and about its future progress. Nuchal translucency measurement in conjunction with maternal serum markers (free-p -human chorionic gonailoiropin and pregnancy-associated plasma protein-A), has been shown to be a highly effective method for screening for aneuploidy. This is further improved by the addition of other more recently discovered first trimester ultrasound markers resulting in detection rates that exceed 90% with a false positive rate of 2.5%. Many fetal structural anomalies can be detected at this gestational age. Recently described first trimester evaluation of the posterior brain (intracranial translucency (IT)) provides an effective screening tool for the presence of open neural tube defects. Doppler measurement of the pulsatility index in the uterine arteries in conjunction with maternal history and examination as well as maternal serum biochemistries helps to accurately establish the risk of developing preeclampsia.
ER  -

SONEK, J.D., K.H. NICOLAIDES a Petr JANKŮ. Screening at 11-13+6 weeks' gestation. \textit{Česká gynekologie}. Česká Republika: Česká Lékařská společnost J.E.Purkyně, 2012, roč.~77, č.~2, s.~92-104. ISSN~1210-7832.

Podrobný výpis o publikaci